Insider Selling: UnitedHealth Group Inc (UNH) Director Sells 198 Shares of Stock

UnitedHealth Group Inc (NYSE:UNH) Director Kenneth Irwin Shine sold 198 shares of the company’s stock in a transaction dated Friday, January 19th. The stock was sold at an average price of $242.55, for a total transaction of $48,024.90. Following the completion of the transaction, the director now owns 1,790,567 shares in the company, valued at $434,302,025.85. The sale was disclosed in a filing with the SEC, which is available through this link.

Kenneth Irwin Shine also recently made the following trade(s):

  • On Tuesday, November 14th, Kenneth Irwin Shine sold 457 shares of UnitedHealth Group stock. The stock was sold at an average price of $211.03, for a total transaction of $96,440.71.

UnitedHealth Group Inc (NYSE UNH) traded up $0.21 during trading hours on Monday, reaching $243.56. 4,009,127 shares of the company were exchanged, compared to its average volume of 3,708,564. UnitedHealth Group Inc has a 12 month low of $156.49 and a 12 month high of $244.35. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.73 and a quick ratio of 0.70. The stock has a market capitalization of $235,490.00, a PE ratio of 22.74, a price-to-earnings-growth ratio of 1.42 and a beta of 0.66.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, beating the Zacks’ consensus estimate of $2.50 by $0.09. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The company had revenue of $52.06 billion during the quarter, compared to analysts’ expectations of $51.57 billion. During the same quarter in the prior year, the company posted $2.11 earnings per share. UnitedHealth Group’s revenue for the quarter was up 9.5% compared to the same quarter last year. equities analysts anticipate that UnitedHealth Group Inc will post 12.52 earnings per share for the current fiscal year.

A number of equities analysts have commented on UNH shares. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 target price on the stock in a research note on Saturday. Goldman Sachs Group started coverage on shares of UnitedHealth Group in a research report on Wednesday, January 3rd. They issued a “buy” rating and a $269.00 price target for the company. Morgan Stanley upped their price target on shares of UnitedHealth Group from $215.00 to $235.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 18th. Credit Suisse Group upped their price target on shares of UnitedHealth Group from $252.00 to $260.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 17th. Finally, ValuEngine cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 5th. Two analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $243.22.

A number of large investors have recently bought and sold shares of the stock. Culbertson A N & Co. Inc. raised its holdings in shares of UnitedHealth Group by 76.4% in the fourth quarter. Culbertson A N & Co. Inc. now owns 2,320 shares of the healthcare conglomerate’s stock worth $511,000 after buying an additional 1,005 shares during the last quarter. Osborn Williams & Donohoe LLC raised its holdings in shares of UnitedHealth Group by 1.6% in the fourth quarter. Osborn Williams & Donohoe LLC now owns 14,229 shares of the healthcare conglomerate’s stock worth $3,137,000 after buying an additional 223 shares during the last quarter. Patten & Patten Inc. TN raised its holdings in shares of UnitedHealth Group by 95.6% in the fourth quarter. Patten & Patten Inc. TN now owns 20,107 shares of the healthcare conglomerate’s stock worth $4,433,000 after buying an additional 9,828 shares during the last quarter. Steward Partners Investment Advisory LLC raised its holdings in shares of UnitedHealth Group by 40.6% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 55,895 shares of the healthcare conglomerate’s stock worth $12,322,000 after buying an additional 16,132 shares during the last quarter. Finally, Winslow Evans & Crocker Inc. raised its holdings in shares of UnitedHealth Group by 59.0% in the fourth quarter. Winslow Evans & Crocker Inc. now owns 4,992 shares of the healthcare conglomerate’s stock worth $1,101,000 after buying an additional 1,852 shares during the last quarter. 86.11% of the stock is owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: This piece was published by American Banking News and is owned by of American Banking News. If you are viewing this piece on another site, it was stolen and republished in violation of US & international copyright and trademark law. The original version of this piece can be read at https://www.americanbankingnews.com/2018/01/22/insider-selling-unitedhealth-group-inc-unh-director-sells-198-shares-of-stock.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Insider Buying and Selling by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply